Brain Cancer

Bifrontal Glioblastoma Multiforme

Male, 26 years

Patient Internal 708782583

ICD-10 code

C71.9 Malignant neoplasm: Brain, Unspecified

Diagnosis (Incl. Metastases/Stage) and Year

December 2014
Bifrontal Glioblastoma Multiforme Midline Glioma, WHO Grade 4, TP53 (+) and IDH1(+) Gene Mutations.

Previous Treatment

Radiation Therapy, Chemotherapy (Temozolomide), Target Therapy (Ipatasertib+Atezolizumab).

Prognosis and Survival Expectation

The prognosis remains poor, with a median survival of ~14 months from diagnosis.

Treatment Provided

Autologous DCV (3 doses) over a period of 1 month.

Patient Survival/Condition and Year
Date of Review: 01/12/2023

The patient survived for 6 years and 5 months after diagnosis. It can be concluded that Immunotherapy, alongside Radiation Therapy, Chemotherapies and Target Therapies, extended patient survival by an estimate of around 5 years.